R.M. Moreno et al. / Journal of Organometallic Chemistry 660 (2002) 62Á
/70
67
3.4. (R)-4-Phenyl-N-(3?phenylpropanoyl)-1,3-
oxazolidin-2-one (10)
Chiralcel-OD column, 95% C6H14*
hol, Fꢂ Tꢂ
0.5 ml minꢀ1
tR(2?S,4S) 65.6 min, tR (2?R,4S) 84.3 min.
M.p. 109.5Á111.0 8C. [a]Dꢂ 186.5 (cꢂ
CH2Cl2). IR (KBr): nꢂ2925, 1775, 1701, 1379, 1329,
1231, 1186, 1105, 1030, 957, 820 cmꢀ1. H-NMR (200
MHz, CDCl3): d (ppm) 1.05 (d, Jvic(CH3,2?-CH) 6.6 Hz,
/
5% isopropyl alco-
/
,
/
25 8C, lꢂ254 nm,
/
ꢂ
/
ꢂ
/
To a cold (0 8C), stirred solution of (R)-4-phenyl-1,3-
oxazolidin-2-one (9) (0.500 g, 3.1 mmol) in anhydrous
THF (10 ml), 2.0 ml (3.4 mmol) of a 1.6 M solution of n-
butyl lithium in hexanes were added with a calibrated
syringe, and stirring was maintained for 0.5 h at the
same temperature. At this point, 0.78 ml (5.6 mmol) of
3-phenylpropanoyl chloride were added in one portion,
and the reaction mixture was slowly warmed to r.t.
When TLC analysis showed that no starting material
remained, the reaction was quenched by the addition of
aqueous saturated ammonium chloride solution (5 ml),
/
/
ꢀ
/
/0.50,
/
1
ꢂ
/
?
3H, CH3), 2.64 (dd, Jgem(3?-CHH)
ꢂ
/
13.4 Hz, Jvic(3?-CH,2?-
13.4
4.2 (m,
5-CHH), 4.61
CH)ꢂ7.2 Hz, 1H, 3?-CHH), 2.98 (dd, Jgem(3?-CHH)
/
ꢂ
/
?
Hz, Jvic(3?-CH?,2?-CH)
9H, Fcꢁ2?-CH), 4.3Á
(dd, Jgem(5-CHH) 8.6 Hz, Jvic(5-CH,4-CH)
5-CHH), 5.21 (dd, Jvic(4-CH,5-CH)
CH?)ꢂ
ꢂ
/
7.8 Hz, 1H, 3?-CHH), 3.9Á
/
/
/
4.4 (m, 2H, Fcꢁ
/
?
ꢂ
/
ꢂ
/
2.6 Hz, 1H,
?
ꢂ
/
8.0 Hz, Jvic(4-CH,5-
/
2.4 Hz, 1H, 4-CH), 7.25 (m, 5H, Ph). 13C-NMR
and extracted with CH2Cl2 (3ꢃ
organic layers were dried over MgSO4 and evaporated
at reduced pressure to afford a crude product that upon
/
20 ml). The combined
(50 MHz, CDCl3): d (ppm) 16.9 (CH3), 39.2 (2?-CH),
39.6 (3?-CH2), 53.5 (4-CH), 65.2 (Fc-CH), 68.3 (5-CH2),
68.5 (Fc-CH), 68.6 (Fc-CH), 68.7 (Fc-CH), 70.2 (Fc-
CH), 84.9 (Fc-Cq), 126.2 (Ph-CH), 128.2 (Ph-CH), 129.1
(Ph-CH), 139.2 (Ph-Cq), 152.7 (1?-Cq), 175.8 (2-Cq).
chromatographic purification (silica gel, C6H14ÁEtOAc
/
mixtures of increasing polarity) yielded 0.859 g (93%) of
the desired (R)-4-phenyl-N-(3-phenylpropanoyl)-1,3-
oxazolidin-2-one (10) as a colourless solid.
MS (CI, NH3) m/eꢂ
/
417 [Mꢁ, 72%], 418 [Mꢁ1ꢁ,
/
100%]. HRMS (CI) Calcd. for C23H24FeNO3: 418.1105.
Found: 418.1089.
M.p. 122.9Á
/
123.8 8C. [a]Dꢂ
/
ꢀ
/
61.0 (cꢂ1.08,
/
CH2Cl2). IR (KBr): nꢂ2923, 1779, 1701, 1653, 1559,
/
1
1456, 1383, 1259, 1200, 1055, 801 cmꢀ1. H-NMR (200
MHz, CDCl3): d (ppm) 2.93 (m, 2H, 3?-CH2), 3.27 (m,
3.6. (R)-4-Phenyl-N-(3?-phenyl-(R)-2?-
methylpropanoyl)-1,3-oxazolidin-2-one (11)
2H, 2?-CH2), 4.27 (dd, Jgem(5-CHH)
ꢂ8.8 Hz,
/
?
Jvic(5-CH, 4-CH)ꢂ
/
3.8 Hz, 1H, 5-CHH), 4.67 (t,
?
Jgem(5-CHH)
5.42 (dd, Jvic(4-CH, 5-CH)
Hz, 1H, 4-CH), 7.2Á
ꢂ
/
Jvic(5-CH, 4-CH)ꢂ
/
8.8 Hz, 1H, 5-CHH),
?
To a cold (ꢀ78 8C) solution of Na[(Me3Si)2N] (0.579
/
ꢂ
/
8.5 Hz, Jvic(4-CH, 5-CH?)
ꢂ
/
3.8
g, 3.18 mmol) in anhydrous THF (10 ml), a solution of
the N-acyloxazolidinone (10) (0.627 g, 2.12 mmol) was
added slowly via syringe. After stirring for 30 min at the
same temperature, a solution of CH3I (0.62 ml, 10
mmol) in anhydrous THF (5 ml) was added via syringe.
/
7.3 (m, 10H, Ph). 13C-NMR (50
MHz, CDCl3): d (ppm) 30.1 (3?-CH2), 37.1 (2?-CH2),
57.5 (4-CH), 69.9 (5-CH2), 125.8 (Ph-CH), 126.1 (Ph-
CH), 128.3 (Ph-CH), 129.1 (Ph-CH), 138.9 (Ph-Cq),
140.2 (Ph-Cq), 154.0 (1?-Cq), 171.7 (2-Cq). MS (CI,
The mixture was stirred at ꢀ78 8C for 3 h, the reaction
/
NH3) m/eꢂ
/
295 [Mꢁ, 7%], 296 [Mꢁ
/
1ꢁ, 100%]. HRMS
was quenched by addition of aqueous saturated ammo-
nium chloride solution (5 ml), and extracted with EtOAc
(CI) Calcd. for C18H18NO3: 296.1287. Found: 296.1290.
(3ꢃ20 ml). The combined organic phases were dried
/
3.5. (S)-4-Ferrocenyl-N-(3?-phenyl-(R)-2?-
methylpropanoyl)-1,3-oxazolidin-2-one (7)
over MgSO4 and evaporated at reduced pressure to
afford a crude product (dr 70:30, according to 1H-NMR
spectroscopy), that upon chromatographic purification
To a cold (ꢀ
/
78 8C) solution of Na[(Me3Si)2N] (50
(silica gel, C6H14ÁEtOAc mixtures of increasing polar-
/
mg, 0.25 mmol) in anhydrous THF (5 ml), a solution of
the N-acyloxazolidinone (6) (70 mg, 0.17 mmol) was
added slowly via syringe. After stirring for 30 min at the
same temperature, a solution of CH3I (53 ml, 0.85 mmol)
in anhydrous THF (5 ml) was added via syringe. The
ity) gave 0.284 g (43%) of the title compound 11 as a
colourless solid.
M.p.
88.9Á
/
90.0 8C.
[a]Dꢂ
/
ꢀ
/
122.5
(cꢂ1.00,
/
CH2Cl2). IR (KBr): nꢂ2923, 1779, 1703, 1603, 1454,
/
1383, 1236, 1198, 1041, 953 cmꢀ1. 1H-NMR (200 MHz,
mixture was stirred at ꢀ
quenched by addition of aqueous saturated ammonium
chloride solution (5 ml), and extracted with EtOAc (3ꢃ
15 ml). The combined organic phases were dried over
MgSO4 and evaporated at reduced pressure to afford a
crude product (94:6 dr) that upon chromatographic
/
78 8C for 7 h, the reaction was
CDCl3): d (ppm) 1.14 (m, 3H, CH3), 2.64 (m, 1H, 3?-
CHH), 3.01 (m, 1H, 3?-CHH), 4.18 (m, 2H, 2?-CHꢁ
/
5-
?
Jvic(5-CH,4-CH)
/
CHH), 4.48 (t, Jgem(5-CHH)
1H, 5-CHH), 5.29 (dd, Jvic(4-CH,5-CH)
ꢂ
/
ꢂ
/
8.8 Hz,
ꢂ
/
8.8 Hz,
?
Jvic(4-CH,5-CH?)
ꢂ
/
3.6 Hz, 1H, 4-CH), 7.19Á
/7.35 (m,
10H, Ph). 13C-NMR (50 MHz, CDCl3): d (ppm) 17.1
(CH3), 39.4 (3?-CH2), 39.6 (2?-CH), 57.6 (4-CH), 69.7
(5-CH2), 125.6 (Ph-CH), 128.2 (Ph-CH), 129.1 (Ph-CH),
139.0 (Ph-Cq), 139.2 (Ph-Cq), 153.2 (1?-Cq), 175.9
purification (silica gel, C6H14ÁEtOAc mixtures of in-
/
creasing polarity) gave 17 mg (24%) of the title
compound 7 as a yellow solid. Conditions for the
HPLC determination of the diastereomeric purity of 7:
(2-Cq). MS (EI) m/eꢂ91 (100%), 118 (83%), 309
/